RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      N,N -(Alkanediyl)bis(phenylacetamide)유도체 합성 및 DNA methyltransferase 저해활성 = Synthesis and DNA methyltransferase inhibitory activity of N,N -(alkanediyl)bis(phenylacetamide) derivatives

      한글로보기

      https://www.riss.kr/link?id=A106205611

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      DNA methyltransferases (DNMTs) are epigenetic enzymes responsible for gene expression in cancer, therefore their inhibitors have been considered as target for the treatment and prevention of cancer. Psammaplin A (PsA) with dimeric disulfide structure ...

      DNA methyltransferases (DNMTs) are epigenetic enzymes responsible for gene expression in cancer, therefore their inhibitors have been considered as target for the treatment and prevention of cancer. Psammaplin A (PsA) with dimeric disulfide structure exhibits excellent DNMT inhibitory activity, but there are synthetic limitations in the development of various derivatives. To develop various DNMT inhibitors that are easy to synthesize, N,N -(alkanediyl) bis(phenylacetamide) derivatives 1-16 were synthesized from 3- or 4-substituted phenylacetic acids and α,ω-diaminoalkanes(NH2(CH2)nNH2, n=2-5) and evaluated for the preliminary screening of DNMT inhibitory activity using PsA as an positive control. The DNMT inhibitory activities (21-91%) of all synthesized compounds were lower than that of PsA (>100%) at 200 μM concentration. Among them, N,N -(pentane-1,5-diyl)bis(2-(3-bromophenyl)acetamide) (12) was found to be most active compound with DNMT inhibition of 91%.

      더보기

      목차 (Table of Contents)

      • 서 론(Introduction) 실험방법(Experimental Methods) 결과 및 고찰(Results and Discussion) 결 론(Conclusion)
      • 서 론(Introduction) 실험방법(Experimental Methods) 결과 및 고찰(Results and Discussion) 결 론(Conclusion)
      더보기

      참고문헌 (Reference)

      1 Rodriguez, A. D., "Two bromotyrosine-cysteine derived metabolites from a sponge" 28 : 4989-, 1987

      2 Baud, M. G., "Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors" 9 : 81-, 2013

      3 Yang, X., "Targeting DNA methylation for epigenetic therapy" 31 : 536-, 2010

      4 Wen, J., "Synthesis, biological evaluation and histone deacetylase inhibiting as cytotoxic agents" 26 : 4372-, 2016

      5 Asgatay, S., "Synthesis and evaluation of analogues of Nphthaloyl-L-tryptophan (RG 108) as inhibitors of DNA methyltransferase 1" 57 : 421-, 2013

      6 Chik, F., "Role of epigenetics in cancer initiation and progression" 720 : 91-, 2011

      7 Halby, L., "Rapid synthesis of new DNMT inhibitors derivatives of procainamide" 13 : 157-, 2012

      8 Piña, I. C., "Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase" 68 : 3866-, 2003

      9 Kim, D., "Psammaplin A, a natural phenolic compound has inhibitory effect on human topoisomerase II and its cytotoxic to cancer cells" 19 : 4085-, 1999

      10 Lee, B. H., "Procainamide is a specific inhibitor of DNA methyltransferase 1" 280 : 40749-, 2005

      1 Rodriguez, A. D., "Two bromotyrosine-cysteine derived metabolites from a sponge" 28 : 4989-, 1987

      2 Baud, M. G., "Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors" 9 : 81-, 2013

      3 Yang, X., "Targeting DNA methylation for epigenetic therapy" 31 : 536-, 2010

      4 Wen, J., "Synthesis, biological evaluation and histone deacetylase inhibiting as cytotoxic agents" 26 : 4372-, 2016

      5 Asgatay, S., "Synthesis and evaluation of analogues of Nphthaloyl-L-tryptophan (RG 108) as inhibitors of DNA methyltransferase 1" 57 : 421-, 2013

      6 Chik, F., "Role of epigenetics in cancer initiation and progression" 720 : 91-, 2011

      7 Halby, L., "Rapid synthesis of new DNMT inhibitors derivatives of procainamide" 13 : 157-, 2012

      8 Piña, I. C., "Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase" 68 : 3866-, 2003

      9 Kim, D., "Psammaplin A, a natural phenolic compound has inhibitory effect on human topoisomerase II and its cytotoxic to cancer cells" 19 : 4085-, 1999

      10 Lee, B. H., "Procainamide is a specific inhibitor of DNA methyltransferase 1" 280 : 40749-, 2005

      11 Holleran, J. L., "Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine" 11 : 3862-, 2005

      12 Quinoa, E., "Phenolic constituents of Psammaplysilla" 28 : 3229-, 1987

      13 Yoo, J., "Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: Implications for the mechanism of inhibition of DNMTs" 8 : e62152-, 2013

      14 Stresman, C., "Modes of action of the DNA methyltransferase inhibitors, azacytidine and decitabine" 125 : 8-, 2008

      15 Ben-Kasus, T., "Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells" 70 : 121-, 2005

      16 Yoo, C. B., "Epigenetic therapy of cancer: Past, present and future" 5 : 37-, 2006

      17 Garcia, J., "Epigenetic profiling of the antitumor natural product psammaplin A and its analogues" 19 : 3637-, 2011

      18 Weber, M., "Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome" 39 : 457-, 2007

      19 Wang, S. -C., "Antroquinonol D, isolated from Antrodia camphorata, with DNA demethylation and anticancer potential" 62 : 5625-, 2014

      20 Graça, I., "Antitumoral effect of the non-nucleoside DNMT inhibitor RG-108 in human prostate cancer cells" 20 : 1803-, 2014

      21 Berger, S. L., "An operational definition of epigenetics" 23 : 781-, 2009

      22 Gadat, A. M., "An Improved synthesis of psammaplin A" 16 : 3330-, 2006

      23 Yamanaka, M., "Altered methylation of multiple genes in carcinogenesis of the prostate" 106 : 382-, 2003

      24 Hoshino, O., "A convenient synthesis of a bromotyrosine derived metabolite psammaplin A, from psammaphysilla sp" 2 : 1561-, 1992

      25 Christman, J. K., "5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitor of DNA methylation: mechanistic studies and their implications for cancer therapy" 21 : 5483-, 2002

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.2 0.2 0.22
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.18 0.403 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼